2026 PRELIMINARY AGENDA

Registration

Pacifica Ballroom

Breakfast Symposium:

Not Accredited for CME

Welcome, Introduction & Program Overview

Lori Daniels, MD, MAS, FACC, FAHA, FESC (UC San Diego)

hsTroponin in the Emergency Department

Martin Than, MD (Christchurch Hospital, New Zealand)

Point of Care hsTroponin: Whole-Blood Testing Comes of Age

Paul Collinson, MA, MB, BChir, FRCPath, MD, FRCP(Edin), FAACC, FESC (City St. George’s University of London)

Troponin I or T? Using Both to Sort Type 1 from Type 2—and Acute from Chronic

Fred Apple, PhD, DABCC (University of Minnesota, Minneapolis, MN)

Making the Call: Practical Lessons in Biomarker Outcome Adjudication

Lori Daniels, MD, MAS, FACC, FAHA, FESC (UC San Diego)

Reflections on the Universal Definition of MI

Nicholas Mills, MD, PhD (University of Edinburgh, UK)

Acute Coronary Syndrome Panel Q&A/Discussion

BREAK / VISIT EXHIBITS 

Everything You Need to Know About Macro Troponins & Troponin Autoantibodies – An Update

Saara Wittfooth, PhD (University of Turku: Turku, Finland)

Do You Need Necrosis? Rethinking Mechanisms of Troponin Release

Ola Hammarsten, MD, PhD (University of Gothenburg, Sweden)

High-Sensitivity Cardiac Troponin: Analytical Pitfalls & Practical Fixes

Robert Fitzgerald, PhD (UC San Diego)

Biomarker-Guided Prevention Interventions in the Emergency Department

Simon Mahler, MD (Wake Forest University, Winston-Salem, NC) 

Breast Arterial Calcification & Cardiovascular Outcomes: a Dual-Prevention Pathway

Lori Daniels, MD, MAS, FACC, FAHA, FESC (UC San Diego)

Using Biomarkers to Advance GDMT ADHEREance

Gregg Fonarow, MD (UC Los Angeles)

Q&A Panel Discussion

LUNCH / VISIT EXHIBITS

Pacifica Ballroom

The Clinical Emergence of Lipoprotein (a)

TBD

Screening in the General Population

Torbjørn Omland, MD, PhD (University of Oslo, Norway)

GDF-15 as a Therapeutic Target

Kristin Aakre, MD, PhD (University of Bergen, Norway)

Markers of Inflammation & Cardiovascular Disease in Chronic Kidney Disease

TBD

Biomarkers for "Precision-Like" Prevention & Population Health

James De Lemos, MD (UT-Southwestern)

Age Matters: Principles for Interpreting Biomarkers in Late Life

Christopher deFilippi, MD, MS, FACC (University. of Maryland, Baltimore, MD)

Q&A Panel Discussion

BREAK / VISIT EXHIBITS

A Digital Biomarker for Peripheral Arterial Disease

Mattheus Ramsis, MD (UC San Diego)

Q&A Discussion

The Bed of the Future

Kevin King, MD, PhD (UC San Diego)

Q&A  

A Better Critical Care Biomarker 

Adrian Picod, MD, PhD (Avicenne Hospital Paris, France)

Q&A

TBD

Torbjørn Omland, MD, PhD (University of Oslo, Norway)

Q&A

Shark Tank Reveal

Lori Daniels, MD, MAS, FACC, FAHA, FESC (UC San Diego), Christopher deFilippi, MD, MS, FACC (University of Maryland, Baltimore, MD)

Concluding Remarks

Lori Daniels, MD, MAS (UC San Diego)